Lilly's Weight Loss Drug Gains Traction After Novo Nordisk's Clinical Trial Setback

In a significant turn of events, shares of Eli Lilly surged following news that competitor Novo Nordisk faced challenges in its clinical trials for a key weight loss drug. This development highlights a growing advantage for Lilly in the realm of obesity treatments, potentially reshaping the competitive landscape of the pharmaceutical industry.

Continue reading

Uncertainty Looms as Trump’s Tariff Threats Impact Australian Stock Market

In a significant development for the Australian financial landscape, fears surrounding potential tariffs imposed by former President Donald Trump are creating ripples across the stock market. Investors are closely monitoring the implications of these tariff threats, especially as they relate to key sectors within the Australian economy.

Continue reading

Bond Market Reacts to Trump's Surprising Victory: Insights from Harley Bassman

In the aftermath of Donald Trump's unexpected victory in the recent elections, the bond market is experiencing significant fluctuations, as detailed by financial analyst Harley Bassman. Investors are grappling with the implications of this political shift, leading to pivotal changes in bond dynamics that could influence economic forecasts moving forward.

Continue reading